Cencora, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cencora, Inc. on May 29, 2026, covering events reported as of May 23, 2026. The filing primarily addresses the appointment of a new Chief Financial Officer and the reaffirmation of the company's financial guidance.
Key Financial Metrics
This filing does not report specific revenue, profit, cash flow, or debt figures for a completed period. However, it discloses the following compensation metrics for the new CFO:
- Annual Base Salary: $1,000,000
- Annual Bonus Target: 100% of base salary
- Sign-on Bonus: $2,000,000 (cash, subject to repayment clawback)
- Restricted Stock Units (RSUs): $6,000,000 value (vesting over three years)
Material Changes
The primary material change is the leadership transition in the finance function:
- Appointment: Eva C. Boratto has been appointed Executive Vice President and Chief Financial Officer, effective June 29, 2026.
- Departure: James F. Cleary is retiring as CFO but will serve in an advisory capacity through the end of 2026.
- Background: Ms. Boratto previously served as CFO of Bath & Body Works, Inc. and held senior finance roles at CVS Health and Merck & Co., Inc.
Guidance, Outlook, and Management Commentary
On May 27, 2026, management reaffirmed its financial outlook for fiscal year 2026 and long-term growth targets:
- Fiscal 2026 Adjusted Diluted EPS: $17.70 to $17.90
- Long-Term Adjusted Operating Income Growth: 7% to 10%
- Long-Term Adjusted Diluted EPS Growth: 10% to 14%
The filing includes standard cautionary notes regarding forward-looking statements and defines non-GAAP measures (Adjusted Operating Income and Adjusted Diluted EPS) used for internal evaluation, noting that reconciliations for forward-looking periods are not provided due to uncertainty.
Investor Verification Checklist
- Verify the effective date of the CFO transition (June 29, 2026) and the transition plan with the retiring CFO.
- Review the full text of the Sign-on Bonus Reimbursement Agreement (Exhibit 10.3) to understand specific clawback conditions.
- Confirm the company's ability to meet the reaffirmed fiscal 2026 EPS guidance of $17.70 to $17.90 given the leadership change.
- Examine the "Risk Factors" in the most recent Form 10-K for details on uncertainties affecting the long-term growth targets.